Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience

被引：0
|
作者：
Maren Bienert
Ingrid Reisinger
Stefanie Srock
Beatrice I Humplik
Christel Reim
Thomas Kroessin
Norbert Avril
Antonio Pezzutto
Dieter L Munz
机构：
[1] Charité—Universitätsmedizin Berlin,Clinic for Nuclear Medicine
[2] Charité—Universitätsmedizin Berlin,Department of Haematology and Oncology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2005年 / 32卷
关键词：
Non-Hodgkin’s lymphoma; Radioimmunotherapy; I-rituximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1225 / 1233
页数：8
相关论文
共 50 条
  • [1] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma:: initial experience
    Bienert, M
    Reisinger, I
    Srock, S
    Humplik, BI
    Reim, C
    Kroessin, T
    Avril, N
    Pezzutto, A
    Munz, DL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (10) : 1225 - 1233
  • [2] Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye J.
    Lee, Seung S.
    Kim, Kyeong M.
    Choi, Tae H.
    Cheon, Gi J.
    Kim, Won S.
    Suh, Cheolwon
    Yang, Sung H.
    Lim, Sang M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 136 - +
  • [3] Safety of 131I-Rituximab Outpatient Radioimmunotherapy of Non-Hodgkin Lymphoma
    Calais, P. J.
    Turner, J. H.
    MEDICAL PHYSICS, 2011, 38 (06)
  • [4] Outpatient 131I-Rituximab Radioimmunotherapy for Non-Hodgkin Lymphoma A Study in Safety
    Calais, Phillipe J.
    Turner, John Harvey
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (08) : 732 - 737
  • [5] Repeated radioimmunotherapy (RIT) with 131I-rituximab for patients with low grade and aggressive relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye Jin
    Lee, Seung-Sook
    Kim, Kyeong Min
    Lim, Sang Moo
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Kang, Hye Jin
    Lee, Seung-Sook
    Byun, Byung Hyun
    Kim, Kyeong Min
    Lim, Ilhan
    Choi, Chang Woon
    Suh, Cheolwon
    Kim, Won Seog
    Nam, Seung-Hyun
    Lee, Soon Il
    Eom, Hyeon Seok
    Shin, Dong-Yeop
    Lim, Sang Moo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 945 - 953
  • [7] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Hye Jin Kang
    Seung-Sook Lee
    Byung Hyun Byun
    Kyeong Min Kim
    Ilhan Lim
    Chang Woon Choi
    Cheolwon Suh
    Won Seog Kim
    Seung-Hyun Nam
    Soon Il Lee
    Hyeon Seok Eom
    Dong-Yeop Shin
    Sang Moo Lim
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 945 - 953
  • [8] Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma
    Dong-Yeop Shin
    Byung Hyun Byun
    Kyeong Min Kim
    Joo Hyun Kang
    Ilhan Lim
    Byung Il Kim
    Seung-Sook Lee
    Chang Woon Choi
    Hye Jin Kang
    Sang Moo Lim
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 825 - 831
  • [9] Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma
    Shin, Dong-Yeop
    Byun, Byung Hyun
    Kim, Kyeong Min
    Kang, Joo Hyun
    Lim, Ilhan
    Kim, Byung Il
    Lee, Seung-Sook
    Choi, Chang Woon
    Kang, Hye Jin
    Lim, Sang Moo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 825 - 831
  • [10] Prognostic Significance of Pretreatment 18F-FDG PET/CT in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Treated by Radioimmunotherapy Using 131I-Rituximab
    Lim, Ilhan
    Park, Joon Yeun
    Kang, Hye Jin
    Hwang, Jae Pil
    Lee, Seung Sook
    Kim, Kyeong Min
    Choi, Tae Hyun
    Yang, Sung Hyun
    Kim, Byung Il
    Choi, Chang Woon
    Lim, Sang Moo
    ACTA HAEMATOLOGICA, 2013, 130 (02) : 74 - 82
12345